LeonaBio, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
LeonaBio, Inc. (LONA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $20.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-31
- LeonaBio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $20.70M, a 0.00% change from fiscal 2024.
- LeonaBio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $20.70M, a 26.86% decline from fiscal 2023.
- LeonaBio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $28.30M, a 38.73% increase from fiscal 2022.
- LeonaBio, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $20.40M, a 51.11% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $20.70M 10-K · filed 2026-03-31 |
| 2024-12-31 | $20.70M 10-K · filed 2026-03-31 |
| 2023-12-31 | $28.30M 10-K · filed 2025-02-27 |
| 2022-12-31 | $20.40M 10-K · filed 2024-02-22 |
| 2021-12-31 | $13.50M 10-K · filed 2023-03-23 |
| 2020-12-31 | $4.30M 10-K · filed 2022-03-28 |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |